An admixture scan in 1,484 African American women with breast cancer

Cancer Epidemiology Biomarkers and Prevention

Volumn 18, Issue 11, 2009, Pages 3110-3117

  Fejerman, Laura ^a   Haiman, Christopher A ^b   Reich, David ^c,e   Tandon, Arti ^c,e   Deo, Rahul C ^c,d   John, Esther M ^f,g   Ingles, Sue A ^b   Ambrosone, Christine B ^h   Bovbjerg, Dana Howard ⁱ   Jandorf, Lina H ^j   Davis, Warren ^h   Ciupak, Gregory ^h   Whittemore, Alice S ^g   Press, Michael F ^b   Ursin, Giske ^b,l   Bernstein, Leslie ^k   Huntsman, Scott ^a   Henderson, Brian E ^b   Ziv, Elad ^a   Freedman, Matthew L ^e,m,n  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

^e MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^f NORTHERN CALIFORNIA CANCER CENTER   (United States)

^g STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^h ROSWELL PARK CANCER INSTITUTE   (United States)

ⁱ UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^j MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^k CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^l UNIVERSITY OF OSLO   (Norway)

^m DANA FARBER HARVARD CANCER CENTER   (United States)

ⁿ DANA FARBER CANCER INSTITUTE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR;

ADULT; AFRICAN AMERICAN; AGED; ALLELE; ARTICLE; BREAST CANCER; CANCER GRADING; CANCER INVASION; CANCER LOCALIZATION; CANCER RISK; CANCER STAGING; CONTROLLED STUDY; EUROPEAN AMERICAN; FEMALE; GENE FREQUENCY; GENE LOCUS; GENETIC ANALYSIS; GENETIC MARKER; GENETIC PREDISPOSITION; HUMAN; MAJOR CLINICAL STUDY; PHENOTYPE; POPULATION RESEARCH; PRIORITY JOURNAL;

ADULT; AFRICAN AMERICANS; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CASE-CONTROL STUDIES; COHORT STUDIES; FEMALE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; MIDDLE AGED; NEOPLASMS, HORMONE-DEPENDENT; PROGNOSIS; PROSPECTIVE STUDIES; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; RISK FACTORS; UNITED STATES; YOUNG ADULT;

EID: 72749125457     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-09-0464     Document Type: Article

References (47)

1. Ries LAG, Eisner MP, Kosary CL, et al. SEER cancer statistics review 1975-2000. Bethesda: National Cancer Institute 2003.
2. Althuis MD, Brogan DD, Coates RJ, et al. Breast cancers among very young premenopausal women (United States). Cancer Causes Control 2003;14:151-160 (Pubitemid 36539521)
3. Joslyn SA, West MM. Racial differences in breast carcinoma survival. Cancer 2000;88:114-123 (Pubitemid 30027686)
4. Fejerman L, Ziv E. Population differences in breast cancer severity. Pharmacogenomics 2008;9:323-333 (Pubitemid 351803935)
5. Chlebowski RT, Chen Z, Rohan T, et al. Ethnicity and breast cancer in the Women's Health Initiative: a unifying concept for unfavorable outcome in African American women [abstract 1008]. J Clin Oncol 2004;22.
6. Amend K, Hicks D, Ambrosone CB. Breast cancer in African-American women: differences in tumor biology from European-American women. Cancer Res 2006;66:8327-8330 (Pubitemid 44449138)
7. Newman LA, Bunner S, Carolin K, et al. Ethnicity related differences in the survival of young breast carcinoma patients. Cancer 2002;95:21-27 (Pubitemid 34743477)
8. Joslyn SA. Hormone receptors in breast cancer: racial differences in distribution and survival. Breast Cancer Res Treat 2002;73:45-59. (Pubitemid 34548165)
9. English WP, Cleveland KE, Barber WH. There is no difference in survival between African-American and white women with breast cancer. Am Surg 2002;68:594-597 (Pubitemid 44897074)
10. Chlebowski RT, Chen Z, Anderson GL, et al. Ethnicity and breast cancer: factors influencing differences in incidence and outcome. J Natl Cancer Inst 2005;97:439-448
11. Rosenberg NA, Li LM, Ward R, Pritchard JK. Informativeness of genetic markers for inference of ancestry. Am J Hum Genet 2003;73:1402-1422 (Pubitemid 38037431)
12. McKeigue PM. Mapping genes that underlie ethnic differences in disease risk: methods for detecting linkage in admixed populations, by conditioning on parental admixture. Am J Hum Genet 1998;63:241-251
13. Collins-Schramm HE, Phillips CM, Operario DJ, et al. Ethnic-difference markers for use in mapping by admixture linkage disequilibrium. Am J Hum Genet 2002;70:737-750 (Pubitemid 34177927)
14. Smith MW, O'Brien SJ. Mapping by admixture linkage disequilibrium: advances, limitations and guidelines. Nat Rev Genet 2005;6:623-632
15. Collins-Schramm HE, Chima B, Operario DJ, Criswell LA, Seldin MF. Markers informative for ancestry demonstrate consistent megabaselength linkage disequilibrium in the African American population. Hum Genet 2003;113:211-219 (Pubitemid 36992279)
16. Freedman ML, Haiman CA, Patterson N, et al. Admixture mapping identifies 8q24 as a prostate cancer risk locus in African-American men. Proc Natl Acad Sci U S A 2006;103:14068-14073
17. Pike MC, Kolonel LN, Henderson BE, et al. Breast cancer in a multiethnic cohort in Hawaii and Los Angeles: risk factor-adjusted incidence in Japanese equals and in Hawaiians exceeds that in whites. Cancer Epidemiol Biomarkers Prev 2002;11:795-800.
18. Kolonel LN, Henderson BE, Hankin JH, et al. A multiethnic cohort in Hawaii and Los Angeles: baseline characteristics. Am J Epidemiol 2000;151:346-357 (Pubitemid 30463612)
19. Marchbanks PA, McDonald JA, Wilson HG, et al. The NICHD Women's Contraceptive and Reproductive Experiences Study: methods and operational results. Ann Epidemiol 2002;12:213-221
20. Ma H, Bernstein L, Ross RK, Ursin G. Hormone-related risk factors for breast cancer in women under age 50 years by estrogen and progesterone receptor status: results from a case-control and a case-case comparison. Breast Cancer Res 2006;8:R39. (Pubitemid 44057560)
21. John EM, Schwartz GG, Koo J, Wang W, Ingles SA. Sun exposure, vitamin D receptor gene polymorphisms, and breast cancer risk in a multiethnic population. Am J Epidemiol 2007;166:1409-1419 (Pubitemid 350209052)
22. John EM, Horn-Ross PL, Koo J. Lifetime physical activity and breast cancer risk in a multiethnic population: the San Francisco Bay Area Breast Cancer Study. Cancer Epidemiol Biomarkers Prev 2003;12:1143-1152 (Pubitemid 37499436)
23. John EM, Hopper JL, Beck JC, et al. The Breast Cancer Family Registry: an infrastructure for cooperative multinational, interdisciplinary and translational studies of the genetic epidemiology of breast cancer. Breast Cancer Res 2004;6:R375-89.
24. Deo RC, Patterson N, Tandon A, et al. A high-density admixture scan in 1,670 African Americans with hypertension. PLoS Genet 2007;3:e196.
25. Reich D, Patterson N, De Jager PL, et al. A whole-genome admixture scan finds a candidate locus for multiple sclerosis susceptibility. Nat Genet 2005;37:1113-1118
26. Patterson N, Hattangadi N, Lane B, et al. Methods for highdensity admixture mapping of disease genes. Am J Hum Genet 2004;74:979-1000. (Pubitemid 38578397)
27. SmithMW, Patterson N, Lautenberger JA, et al. A high-density admixture map for disease gene discovery in African Americans. Am J Hum Genet 2004;74:1001-1013
28. Carey LA, Perou CM, Livasy CA, et al. Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. JAMA 2006;295:2492-2502
29. Millikan RC, Newman B, Tse CK, et al. Epidemiology of basal-like breast cancer. Breast Cancer Res Treat 2008;109:123-139
30. Bauer KR, Brown M, Cress RD, Parise CA, Caggiano V. Descriptive analysis of estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the so-called triple-negative phenotype: a population-based study from the California Cancer Registry. Cancer 2007;109:1721-1728 (Pubitemid 46668532)
31. Stacey SN, Manolescu A, Sulem P, et al. Common variants on chromosome 5p12 confer susceptibility to estrogen receptor-positive breast cancer. Nat Genet 2008;40:703-706 (Pubitemid 351748861)
32. Stacey SN, Manolescu A, Sulem P, et al. Common variants on chromosomes 2q35 and 16q12 confer susceptibility to estrogen receptorpositive breast cancer. Nat Genet 2007;39:865-869 (Pubitemid 47014497)
33. Hunter DJ, Kraft P, Jacobs KB, et al. A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer. Nat Genet 2007;39:870-874 (Pubitemid 47014500)
34. Easton DF, Pooley KA, Dunning AM, et al. Genome-wide association study identifies novel breast cancer susceptibility loci. Nature 2007;447:1087-1093 (Pubitemid 47014426)
35. Gold B, Kirchhoff T, Stefanov S, et al. Genome-wide association study provides evidence for a breast cancer risk locus at 6q22.33. Proc Natl Acad Sci U S A 2008;105:4340-4345 (Pubitemid 351754382)
36. Ghoussaini M, Song H, Koessler T, et al. Multiple loci with different cancer specificities within the 8q24 gene desert. J Natl Cancer Inst 2008;100:962-966 (Pubitemid 351957516)
37. Garcia-Closas M, Hall P,Nevanlinna H, et al. Heterogeneity of breast cancer associations with five susceptibility loci by clinical and pathological characteristics. PLoS Genet 2008;4:e1000054. (Pubitemid 351656691)
38. Udler MS, Meyer KB, Pooley KA, et al. FGFR2 variants and breast cancer risk: fine-scale mapping using African American studies and analysis of chromatin conformation. Hum Mol Genet 2009;18:1692-1703
39. Easton DF, Eeles RA. Genome-wide association studies in cancer. Hum Mol Genet 2008;17:R109-15.
40. Thomas G, Jacobs KB, Kraft P, et al. A multistage genome-wide association study in breast cancer identifies two new risk alleles at 1p11.2 and 14q24.1 (RAD51L1). Nat Genet 2009;41:579-584
41. Olopade OI, Ikpatt FO, Dignam JJ, et al. "Intrinsic Gene Expression" subtypes correlated with grade and morphometric parameters reveal a high proportion of aggressive basal-like tumors among black women of African ancestry [abstract 9509]. J Clin Oncol 2004;22.
42. Tishkoff SA, Reed FA, Friedlaender FR, et al. The genetic structure and history of Africans and African Americans. Science 2009;324:1035-1044
43. Ademuyiwa FO, Olopade OI. Racial differences in genetic factors associated with breast cancer. Cancer Metastasis Rev 2003;22:47-53. (Pubitemid 36363513)
44. Fisher B, Costantino JP,Wickerham DL, et al. Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. J Natl Cancer Inst 1998;90:1371-1388 (Pubitemid 28439961)
45. Cunningham JE, Butler WM. Racial disparities in female breast cancer in South Carolina: clinical evidence for a biological basis. Breast Cancer Res Treat 2004;88:161-176
46. Cummings SR, Eckert S, Krueger KA, et al. The effect of raloxifene on risk of breast cancer in postmenopausal women: results from the MORE randomized trial. Multiple Outcomes of Raloxifene Evaluation. JAMA 1999;281:2189-2197 (Pubitemid 29275701)
47. Dunn BK, Wickerham DL, Ford L. Prevention of hormone-related cancers: breast cancer. J Clin Oncol 2005;23:357-367 (Pubitemid 46209965)